Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand
Background: Disseminated fungal infections are common presenting opportunistic infections among AIDS patients in developing countries. Primary prophylaxis with itraconazole has been shown to be effective in northern Thailand. This study aimed to compare the efficacy of fluconazole vs itraconazole as...
Saved in:
Main Authors: | Chaiwarith R., Fakthongyoo A., Praparattanapan J., Boonmee D., Sirisanthana T., Supparatpinyo K. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-80053949888&partnerID=40&md5=06b375ba1cb39b0bcd53983baefec2e4 http://www.ncbi.nlm.nih.gov/pubmed/21916838 http://cmuir.cmu.ac.th/handle/6653943832/2953 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Itraconazole vs fluconazole as a primary prophylaxis for fungal infections in HIV-infected patients in Thailand
by: Romanee Chaiwarith, et al.
Published: (2018) -
A controlled trial of itraconazole as primary prophylaxis for systemic fungal infections in patients with advanced human immunodeficiency virus infection in Thailand
by: Chariyalertsak S., et al.
Published: (2014) -
Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-infected patients who had CD4+ cell count <200 cells/mm(3) but undetectable plasma HIV-1 RNA: an open-label randomized controlled trial
by: Chaiwarith R., et al.
Published: (2014) -
Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
by: Romanee Chaiwarith, et al.
Published: (2018) -
Discontinuation of primary and secondary prophylaxis for opportunistic infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 but Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
by: Chaiwarith R., et al.
Published: (2014)